Dopavision

Berlin, Germany

Dopavision is a therapeutic company developing a digital therapeutic for myopia.

$14.2M raised

Jul 2021

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Dopavision raised?

Dopavision has raised $14.2M in total funding. The most recent round was Series A. The last funding was announced in July 2021.

Who are Dopavision's investors?

Dopavision's investors include Seventure Partners, Boehringer Ingelheim Venture Fund, dRx Capital, Novartis Pharma, Flyinghealth.

Where is Dopavision headquartered?

Dopavision is headquartered in Berlin, Germany.

What does Dopavision do?

Dopavision is a therapeutic company developing a digital therapeutic for myopia.

What stage is Dopavision at?

Dopavision is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 14, 2021.

MLA

"Dopavision — Funding & Investors." VCBacked, July 14, 2021, https://www.vcbacked.co/company/dopavision. Accessed July 3, 2026.

APA

VCBacked. (2021). Dopavision — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/dopavision

Wikipedia (cite web)

{{cite web |title=Dopavision — Funding & Investors |url=https://www.vcbacked.co/company/dopavision |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 14, 2021.